scholarly journals Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes

2021 ◽  
Author(s):  
I-Chia Liu ◽  
Adam L. Holtzman ◽  
Ronny L. Rotondo ◽  
Daniel J. Indelicato ◽  
Sridharan Gururangan ◽  
...  
Keyword(s):  
Acute Toxicity ◽  
Disease Control ◽  
Proton Therapy ◽  
Adult Medulloblastoma

Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes

2021 ◽  
Author(s):  
I.-C.hia Liu ◽  
Adam L. Holtzman ◽  
Ronny L. Rotondo ◽  
Daniel J. Indelicato ◽  
Sridharan Gururangan ◽  
...  
Keyword(s):  
Acute Toxicity ◽  
Disease Control ◽  
Proton Therapy ◽  
Adult Medulloblastoma

Prospectively registered acute toxicity in breast cancer patients undergoing adjuvant intensity modulated proton therapy

2020 ◽  
Vol 138 ◽  
pp. S85
Author(s):  
K. Verhoeven ◽  
T. Opbroek ◽  
G. Vilches-Freixas ◽  
K. Limpens ◽  
J. Mannens ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Acute Toxicity ◽  
Cancer Patients ◽  
Proton Therapy ◽  
Breast Cancer Patients ◽  
Intensity Modulated Proton Therapy ◽  
Intensity Modulated

scholarly journals Adult medulloblastoma following fractionated proton therapy for acoustic neuroma

2012 ◽  
Vol 2 (1) ◽  
pp. 113-118
Author(s):  
Mark N. Jabbour ◽  
Fady B. Geara ◽  
Roula Hourani ◽  
Badih Adada ◽  
Jean G. Rebeiz ◽  
...  
Keyword(s):  
Acoustic Neuroma ◽  
Proton Therapy ◽  
Adult Medulloblastoma

scholarly journals Proton Therapy for Craniospinal Radiochemotherapy Reduces Myelotoxicity and Improves Chemotherapy Completion in Adult Medulloblastoma

2019 ◽  
Vol 105 (1) ◽  
pp. S141-S142
Author(s):  
C. Lynch ◽  
K.G. Petras ◽  
W.F. Hartsell ◽  
J.H.C. Chang ◽  
S. Grimm ◽  
...  
Keyword(s):  
Proton Therapy ◽  
Adult Medulloblastoma

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 353-353
Author(s):  
Joseph Junyong Park ◽  
Carla Hajj ◽  
Marsha Reyngold ◽  
Weiji Shi ◽  
Zhigang Zhang ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Radiation Therapy ◽  
Acute Toxicity ◽  
Disease Control ◽  
Induction Chemotherapy ◽  
Hematologic Toxicity ◽  
Unresectable Pancreatic Cancer ◽  
Stereotactic Body Radiation ◽  
Intensity Modulated ◽  
Significant Difference

353 Background: Stereotactic body radiation therapy (SBRT) is an emerging treatment option for unresectable pancreatic cancer, and may be more effective and less toxic than intensity modulated radiation therapy (IMRT). Methods: We retrospectively reviewed unresectable stage I-III pancreatic adenocarcinoma treated with SBRT (5 fractions, 30-33Gy) or IMRT (25-28 fractions, 45-56Gy with concurrent chemotherapy) between 2008-2016 at our institution. The groups were compared with respect to overall survival (OS), local failure (LF), distant failure (DF), any failure (AF), proportion of patients becoming resectable, and incidence of acute toxicity. Competing risks methods were used for univariate (UVA) and multivariate analysis (MVA) for LF, DF and AF. All endpoints were calculated from end of RT. Results: Median follow-up for surviving patients was 12.9 months. 44 patients received SBRT and 226 patients received IMRT. Patients who received SBRT were older (45% vs 29% > 70 years old, p = 0.05). Otherwise there was no significant difference in baseline characteristics, including stage and duration of induction chemotherapy. On MVA, there was no significant difference in OS, LF, DF, or AF between IMRT and SBRT (p = 0.73, 0.81, 0.44, and 0.39 respectively). Median OS was 15.7 months, and the 1-year rate of LF was 34.4% for SBRT and 30.2% for IMRT. Response to induction chemotherapy was associated with longer OS (p = 0.03). There was no significant difference in the proportion of patients who were subsequently resected between IMRT (17%) and SBRT (7%; p = 0.11). Significantly more IMRT patients experienced acute G2+ GI toxicity (24% vs. 7%, p = 0.008), G2+ fatigue (42% vs. 7%, p < 0.0001), and G3+ hematologic toxicity (26% vs. 5%, p = 0.001) compared to SBRT. Conclusions: SBRT achieves similar disease control outcomes as IMRT, and is associated with less acute toxicity. This data suggests SBRT is an attractive technique for pancreatic radiotherapy because of improved convenience and tolerability with equivalent efficacy. However, the lack of observed advantages in disease control with this moderate-dose SBRT regimen suggests a role for increasing SBRT dose, if this can be accomplished without significant increase in toxicity.

Acute Toxicity Profile of Patients with Low-grade Gliomas and Meningiomas Receiving Proton Therapy

2014 ◽  
Vol 37 (5) ◽  
pp. 438-443 ◽  
Author(s):  
Genevieve Maquilan ◽  
Surbhi Grover ◽  
Michelle Alonso-Basanta ◽  
Robert A. Lustig
Keyword(s):  
Acute Toxicity ◽  
Proton Therapy ◽  
Low Grade ◽  
Toxicity Profile ◽  
Low Grade Gliomas

Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer

2017 ◽  
Vol 23 (2) ◽  
pp. 353-360 ◽  
Author(s):  
Koichiro Nakajima ◽  
Hiromitsu Iwata ◽  
Hiroyuki Ogino ◽  
Yukiko Hattori ◽  
Shingo Hashimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Acute Toxicity ◽  
Proton Therapy ◽  
Localized Prostate Cancer ◽  
Image Guided
Sign in / Sign up

Export Citation Format

Share Document